EUVIMEDEUVIMED entdecken
Open Access

Leveraging host-cell modulators of adeno-associated vector transduction to tailor viral biodistribution

Katie Kubek-Luck, Jason Velazquez, Xiaorui Yao, Joseph Gabriels, Charles Hsu, Sanjay Arora, Lara Bontadelli, Yoann Gilbart, Fumiaki Aihara, Hui Li, Fadela Bouadjemi, James Ooi und 6 weitere

Molecular Therapy · 2026-11 · 34 (11) · 6329-6345

DOI: 10.1016/j.ymthe.2026.08.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-11. Verfasst von Katie Kubek-Luck und 17 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research, Novartis, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Transduction, Genetic. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical successes in gene therapy using adeno-associated vectors (AAVs) are offering a hopeful path toward the correction of several monogenic disorders. At its core, AAV gene delivery relies on multiple interactions between the capsid or vector genome and numerous host-cell factors, a complex process that remains incompletely understood. Whether different serotypes similarly hijack the intracellular machinery in a cell, and whether these processes are necessarily conserved across species, are not known. To identify host factors enabling or preventing transduction across species or serotypes, CRISPR-Cas9 whole-genome knockdown screens were conducted in mouse (AML12) and human (HuH-7) cell lines before transduction with AAV2 or AAV9. Key common entry factors (AAVR, GPR108) were confirmed, with many other serotype- and/or species-specific host-cell modulators identified. Interestingly, while serotype-specific differences were observed for successful transduction of a specific cell line, species-specific divergences were even more striking when comparing results across murine and human cells for the same serotype. Leveraging these data, we developed a novel approach to detarget liver transduction by transiently downregulating the expression of key entry factors in this tissue using GalNac-small interfering RNAs (siRNAs) prior to AAV9 administration. Such manipulation not only blunted hepatic transduction but also redirected the vector to other transduction-permissive tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic VectorsTransduction, GeneticAnimalsHumansMiceCell LineLiverGenetic TherapyCRISPR-Cas SystemsTissue Distribution

Stichwörter der Autor:innen

AAV viral vectorgene therapyhepatotoxicityhost factorsliversafetytraffickingtransductionwhole-genome screen

Autor:innen und Institutionen

  • Biomedical Research, Novartis, Cambridge, MA 02139, USA.
  • Biomedical Research, Novartis, Basel, Switzerland.
  • Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
  • Biomedical Research, Novartis, Cambridge, MA 02139, USA. Electronic address: eloise.hudry@novartis.com.

Zitieren

APA

Kubek-Luck, K., Velazquez, J., Yao, X., Gabriels, J., Hsu, C., Arora, S., Bontadelli, L., Gilbart, Y., Aihara, F., Li, H., Bouadjemi, F., Ooi, J., Nunes, J., Sigoillot, F., Weiler, J., Meseck, E., Mansfield, K., & Hudry, E. (2026). Leveraging host-cell modulators of adeno-associated vector transduction to tailor viral biodistribution. Molecular Therapy, 34(11), 6329-6345. https://doi.org/10.1016/j.ymthe.2026.08.024

Vancouver

Kubek-Luck K, Velazquez J, Yao X, Gabriels J, Hsu C, Arora S, et al. Leveraging host-cell modulators of adeno-associated vector transduction to tailor viral biodistribution. Molecular Therapy. 2026;34(11):6329-6345. doi:10.1016/j.ymthe.2026.08.024

BibTeX
@article{KubekLuck2026,
  author = {Kubek-Luck, Katie and Velazquez, Jason and Yao, Xiaorui and Gabriels, Joseph and Hsu, Charles and Arora, Sanjay and Bontadelli, Lara and Gilbart, Yoann and Aihara, Fumiaki and Li, Hui and Bouadjemi, Fadela and Ooi, James and Nunes, Jairo and Sigoillot, Frederic and Weiler, Jan and Meseck, Emily and Mansfield, Keith and Hudry, Eloise},
  title = {Leveraging host-cell modulators of adeno-associated vector transduction to tailor viral biodistribution},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {11},
  pages = {6329--6345},
  doi = {10.1016/j.ymthe.2026.08.024}
}
Kostenlos starten →